From Biodata to Digital Medicine: Developing Data – Driven Innovations 2021


From Biodata to Digital Medicine: Developing Data – Driven Innovations 2021

Join us for a fully interactive 3-day event to help develop your #digitalmedicine innovation for commercial use. Discuss your challenges with prominent entrepreneurs, investors and business development professionals.

Dates Monday, January 18, 2021 to Wednesday, January 20, 2021 - Download as vCalendar
Venue Virtual event
Contact Name Catherine Holmes
Email ch22@sanger.ac.uk
Website Event website

Event details:

Application and bursary deadline14 December 2020

This workshop will focus on how to identify and develop opportunities in digital medicine emerging at the interface of biodata and technology.  It is aimed at professionals involved in the translation of early-stage technologies who want to further their knowledge on how to develop innovation into regulated healthcare products and services.

The workshop will bring together attendees and experts to discuss and share practical advice on developing opportunities in digital medicine.

For example, we will address questions such as:

  • Exploring the digital medicine landscape
  • From biodata to therapeutic intervention
  • Developing a digital medicine product
  • What is the role (and value) of biodata?
  • Developing a funding strategy – the investor perspective

Who should attend?
If you are working as a business development manager, a technology transfer professional, investment analyst, innovation funder, or you are an entrepreneur or an academic researcher involved in digital medicine or digital health; this workshop is for you.

 

The Wellcome Sanger Institute is one of the premier centres of genomic discovery and understanding in the world. It leads ambitious collaborations across the globe to provide the foundations for further research and transformative healthcare innovations.